Glycaemic variability is associated with all-cause mortality in COVID-19 patients with ARDS, a retrospective subcohort study

Glycaemic variability is associated with all-cause mortality in COVID-19 patients with ARDS, a retrospective subcohort study

Abstract There is high mortality among intensive care unit (ICU) patients with acute respiratory distress syndrome (ARDS) caused by coronavirus disease (COVID-19). Important factors for COVID-19 mortality are diabetes status and elevated fasting plasma glucose (FPG). However, the effect of glycaemic...

Full description

Bibliographic Details
Main Authors: Bojan Hartmann, Marlo Verket, Paul Balfanz, Niels-Ulrik Hartmann, Malte Jacobsen, Julia Brandts, Michael Dreher, Nils Kossack, Dennis Häckl, Nikolaus Marx, Dirk Müller-Wieland
Format: Article
Language:English
Published: Nature Portfolio 2022-06-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-022-13816-8

Internet

https://doi.org/10.1038/s41598-022-13816-8

Similar Items